Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Measuring US Pharmaceutical Industry R&D SpendingGolec, Joseph ; Vernon, JohnPharmacoEconomics, 2008-01, Vol.26 (12), p.1005-1017 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary FibrosisJenkins, R Gisli ; Moore, Bethany B ; Chambers, Rachel C ; Eickelberg, Oliver ; Königshoff, Melanie ; Kolb, Martin ; Laurent, Geoffrey J ; Nanthakumar, Carmel B ; Olman, Mitchell A ; Pardo, Annie ; Selman, Moises ; Sheppard, Dean ; Sime, Patricia J ; Tager, Andrew M ; Tatler, Amanda L ; Thannickal, Victor J ; White, Eric SAmerican journal of respiratory cell and molecular biology, 2017-05, Vol.56 (5), p.667-679 [Periódico revisado por pares]United States: American Thoracic SocietyTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Innovation in the pharmaceutical industry: New estimates of R&D costsDiMasi, Joseph A. ; Grabowski, Henry G. ; Hansen, Ronald W.Journal of health economics, 2016-05, Vol.47, p.20-33 [Periódico revisado por pares]Netherlands: Elsevier B.VTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
The 8th International Congress on Cutaneous Adverse Drug Reactions, Taiwan, 2013: Focus on Severe Cutaneous Adverse ReactionsDodiuk-Gad, Roni P. ; Chung, Wen-Hung ; Yang, Chih-Hsun ; Lu, Chun-Wei ; Hui, Rosaline Chung-Yee ; Shear, Neil H.Drug safety, 2014-06, Vol.37 (6), p.459-464 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Congress should clarify the circumstances under which drug makers can communicate results on comparative effectivenessKlasmeier, ColeenHealth Affairs, 2012-10, Vol.31 (10), p.2220-2224 [Periódico revisado por pares]United States: The People to People Health Foundation, Inc., Project HOPETexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research ConsortiumSager, Philip T., MD ; Seltzer, Jonathan, MD ; Turner, J. Rick, PhD ; Anderson, Jeffrey L., MD ; Hiatt, William R., MD ; Kowey, Peter, MD ; Prochaska, Judith J., PhD, MPH ; Stockbridge, Norman, MD, PhD ; White, William B., MDThe American heart journal, 2015-04, Vol.169 (4), p.486-495 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Pharmaceutical Policy In ChinaSun, Qiang ; Santoro, Michael A ; Meng, Qingyue ; Liu, Caitlin ; Eggleston, KarenHealth Affairs, 2008-07, Vol.27 (4), p.1042-1050 [Periódico revisado por pares]United States: Health AffairsTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensusNation, Roger L, Prof ; Li, Jian, Prof ; Cars, Otto, Prof ; Couet, William, Prof ; Dudley, Michael N, Pharm D ; Kaye, Keith S, Prof ; Mouton, Johan W, Prof ; Paterson, David L, Prof ; Tam, Vincent H, Prof ; Theuretzbacher, Ursula, PhD ; Tsuji, Brian T, Pharm D ; Turnidge, John D, ProfThe Lancet infectious diseases, 2015-02, Vol.15 (2), p.225-234 [Periódico revisado por pares]United States: Elsevier LtdTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012Vilhelmsson, Andreas ; Davis, Courtney ; Mulinari, Shai Lexchin, JoelPLoS medicine, 2016-01, Vol.13 (1), p.e1001945-e1001945 [Periódico revisado por pares]United States: Public Library of ScienceTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industryToole, Andrew A.Research policy, 2012-02, Vol.41 (1), p.1-12 [Periódico revisado por pares]Amsterdam: Elsevier B.VTexto completo disponível |